IVIG for Guillain-Barré Syndrome from China
IVIG for Guillain-Barré syndrome is an intravenous immunoglobulin product pooled from thousands of donors, used to treat autoimmune neuropathies. It is a modified blood fraction with therapeutic anti-inflammatory properties. This product is classified under tariff item 3002.12.00 as a blood fraction for therapeutic use.
Duty Rate — China → Canada
0%
Import Tips
• Include the product's regulatory approval documentation from Health Canada
• Ensure the product is not classified as a diagnostic reagent, which would be excluded from Chapter 30
• Verify that the product is not a food or beverage, which would fall under Section IV